STAT April 21, 2020
Lev Facher

WASHINGTON — Francis Collins hasn’t set foot on the National Institutes of Health’s campus in Bethesda, Md., for the last month.

But the NIH director says he’s working harder than he has in his nearly five decades in science — never rising later than 5 a.m. and rarely stopping work before 10 p.m. to make sure the $39 billion biomedical research agency continues to function during the coronavirus pandemic.

Collins’ agency has already assumed a central role in the federal government’s coronavirus response. Tony Fauci, who leads the NIH’s infectious disease research institute, has become a household name across America. President Trump visited the NIH for the first time during his presidency last month. And last week, the NIH announced...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Healthcare System, Market Research, Patient / Consumer, Provider, Trends
ATA Action Raises Concerns Over DEA Telemedicine Proposed Rule
The Perfect Storm facing the Healthcare Workforce: Eight Current Issues frame the Challenge
DEA's draft special telehealth reg rule should be tossed, healthcare orgs say
Express Scripts, Caremark, Optum Rx plan to appeal effort to block FTC lawsuit
Trump administration, pharma clash: 4 notes

Share This Article